Coronavirus Test Kits Market in North America 2023-2027

PUBLISHED: October 5, 2023

PAGES: 147 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

List of Tables

Test Kits Market In North America 2023-2027

The test kits market in North America is forecasted to grow by USD -8.77 bn during 2022-2027, decelerating at a CAGR of -23.81% during the forecast period. The report on the test kits market in North America provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising adoption of rapid coronavirus test kits, fastrack approval of coronavirus diagnostic kits, and government initiatives to boost sales of coronavirus test kits.

Market Scope
Base Year	2022
End Year	2027
Series Year	2023-2027
Growth Momentum	Accelerate
YOY 2023	-14.83%
CAGR	-23.81%
Incremental Value	$-8.77bn

Technavio's test kits market in North America is segmented as below:

By End-user

Government
Non-government

By Type

Rapid test kit
RT-PCR
Others

This study identifies the launch of new covid-19 test kits as one of the prime reasons driving the test kits market in North America growth during the next few years. Also, emergence of new covid-19 variants and advancements in technology to develop rapid and accurate test kits will lead to sizable demand in the market.

The report on the test kits market in North America covers the following areas:

Test kits market in North America sizing
Test kits market in North America forecast
Test kits market in North America industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading test kits market in North America vendors that include Abbott Laboratories, Advaite Inc., Becton Dickinson and Co., Biomedomics Inc., bioMerieux SA, Cellex Inc., Co Diagnostics Inc., Cue Health Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Laboratory Corp. of America Holdings, Mammoth Biosciences Inc., MyBioSource Inc., QIAGEN NV, Quidelortho Corp., RayBiotech Life Inc., Robert Bosch GmbH, SHERLOCK BIOSCIENCES, Talis Biomedical Corp., and Thermo Fisher Scientific Inc.. Also, the test kits market in North America analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR43251

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary €" Chart on Market Overview
Exhibit 02: Executive Summary €" Data Table on Market Overview
Exhibit 03: Executive Summary €" Chart on Country Market Characteristics
Exhibit 04: Executive Summary €" Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary €" Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary €" Chart on Market Segmentation by Type
Exhibit 07: Executive Summary €" Chart on Incremental Growth
Exhibit 08: Executive Summary €" Data Table on Incremental Growth
Exhibit 09: Executive Summary €" Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on North America: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 18: Five forces analysis - Comparison between 2022 and 2027
4.2 Bargaining power of buyers
Exhibit 19: Chart on Bargaining power of buyers €" Impact of key factors 2022 and 2027
4.3 Bargaining power of suppliers
Exhibit 20: Bargaining power of suppliers €" Impact of key factors in 2022 and 2027
4.4 Threat of new entrants
Exhibit 21: Threat of new entrants €" Impact of key factors in 2022 and 2027
4.5 Threat of substitutes
Exhibit 22: Threat of substitutes €" Impact of key factors in 2022 and 2027
4.6 Threat of rivalry
Exhibit 23: Threat of rivalry €" Impact of key factors in 2022 and 2027
4.7 Market condition
Exhibit 24: Chart on Market condition - Five forces 2022 and 2027

5 Market Segmentation by End-user

5.1 Market segments
Exhibit 25: Chart on End-user - Market share 2022-2027 (%)
Exhibit 26: Data Table on End-user - Market share 2022-2027 (%)
5.2 Comparison by End-user
Exhibit 27: Chart on Comparison by End-user
Exhibit 28: Data Table on Comparison by End-user
5.3 Government - Market size and forecast 2022-2027
Exhibit 29: Chart on Government - Market size and forecast 2022-2027 ($ billion)
Exhibit 30: Data Table on Government - Market size and forecast 2022-2027 ($ billion)
Exhibit 31: Chart on Government - Year-over-year growth 2022-2027 (%)
Exhibit 32: Data Table on Government - Year-over-year growth 2022-2027 (%)
5.4 Non-government - Market size and forecast 2022-2027
Exhibit 33: Chart on Non-government - Market size and forecast 2022-2027 ($ billion)
Exhibit 34: Data Table on Non-government - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Chart on Non-government - Year-over-year growth 2022-2027 (%)
Exhibit 36: Data Table on Non-government - Year-over-year growth 2022-2027 (%)
5.5 Market opportunity by End-user
Exhibit 37: Market opportunity by End-user ($ billion)
Exhibit 38: Data Table on Market opportunity by End-user ($ billion)

6 Market Segmentation by Type

6.1 Market segments
Exhibit 39: Chart on Type - Market share 2022-2027 (%)
Exhibit 40: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 41: Chart on Comparison by Type
Exhibit 42: Data Table on Comparison by Type
6.3 Rapid test kit - Market size and forecast 2022-2027
Exhibit 43: Chart on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Data Table on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
Exhibit 45: Chart on Rapid test kit - Year-over-year growth 2022-2027 (%)
Exhibit 46: Data Table on Rapid test kit - Year-over-year growth 2022-2027 (%)
6.4 RT-PCR - Market size and forecast 2022-2027
Exhibit 47: Chart on RT-PCR - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Data Table on RT-PCR - Market size and forecast 2022-2027 ($ billion)
Exhibit 49: Chart on RT-PCR - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on RT-PCR - Year-over-year growth 2022-2027 (%)
6.5 Others - Market size and forecast 2022-2027
Exhibit 51: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 52: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 53: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Type
Exhibit 55: Market opportunity by Type ($ billion)
Exhibit 56: Data Table on Market opportunity by Type ($ billion)

7 Customer Landscape

7.1 Customer landscape overview
Exhibit 57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation
Exhibit 58: Chart on Market share By Geographical Landscape - 2022-2027 (%)
Exhibit 59: Data Table on Market share By Geographical Landscape - 2022-2027 (%)
8.2 Geographic comparison
Exhibit 60: Chart on Geographic comparison
Exhibit 61: Data Table on Geographic comparison
8.3 US - Market size and forecast 2022-2027
Exhibit 62: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 63: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 64: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2022-2027 (%)
8.4 Canada - Market size and forecast 2022-2027
Exhibit 66: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 67: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 68: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 69: Data Table on Canada - Year-over-year growth 2022-2027 (%)
8.5 Mexico - Market size and forecast 2022-2027
Exhibit 70: Chart on Mexico - Market size and forecast 2022-2027 ($ billion)
Exhibit 71: Data Table on Mexico - Market size and forecast 2022-2027 ($ billion)
Exhibit 72: Chart on Mexico - Year-over-year growth 2022-2027 (%)
Exhibit 73: Data Table on Mexico - Year-over-year growth 2022-2027 (%)
8.6 Market opportunity By Geographical Landscape
Exhibit 74: Market opportunity By Geographical Landscape ($ billion)
Exhibit 75: Data Table on Market opportunity By Geographical Landscape ($ billion)

9 Drivers, Challenges, and Trends

9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Exhibit 76: Impact of drivers and challenges in 2022 and 2027
9.4 Market trends

10 Vendor Landscape

10.1 Overview
10.2 Vendor landscape
Exhibit 77: Overview on Criticality of inputs and Factors of differentiation
10.3 Landscape disruption
Exhibit 78: Overview on factors of disruption
10.4 Industry risks
Exhibit 79: Impact of key risks on business

11 Vendor Analysis

11.1 Vendors covered
Exhibit 80: Vendors covered
11.2 Market positioning of vendors
Exhibit 81: Matrix on vendor position and classification
11.3 Abbott Laboratories
Exhibit 82: Abbott Laboratories - Overview
Exhibit 83: Abbott Laboratories - Business segments
Exhibit 84: Abbott Laboratories - Key news
Exhibit 85: Abbott Laboratories - Key offerings
Exhibit 86: Abbott Laboratories - Segment focus
11.4 Advaite Inc.
Exhibit 87: Advaite Inc. - Overview
Exhibit 88: Advaite Inc. - Product / Service
Exhibit 89: Advaite Inc. - Key offerings
11.5 Becton Dickinson and Co.
Exhibit 90: Becton Dickinson and Co. - Overview
Exhibit 91: Becton Dickinson and Co. - Business segments
Exhibit 92: Becton Dickinson and Co. - Key news
Exhibit 93: Becton Dickinson and Co. - Key offerings
Exhibit 94: Becton Dickinson and Co. - Segment focus
11.6 Biomedomics Inc.
Exhibit 95: Biomedomics Inc. - Overview
Exhibit 96: Biomedomics Inc. - Product / Service
Exhibit 97: Biomedomics Inc. - Key offerings
11.7 bioMerieux SA
Exhibit 98: bioMerieux SA - Overview
Exhibit 99: bioMerieux SA - Product / Service
Exhibit 100: bioMerieux SA - Key news
Exhibit 101: bioMerieux SA - Key offerings
11.8 Cellex Inc.
Exhibit 102: Cellex Inc. - Overview
Exhibit 103: Cellex Inc. - Product / Service
Exhibit 104: Cellex Inc. - Key offerings
11.9 Co Diagnostics Inc.
Exhibit 105: Co Diagnostics Inc. - Overview
Exhibit 106: Co Diagnostics Inc. - Product / Service
Exhibit 107: Co Diagnostics Inc. - Key news
Exhibit 108: Co Diagnostics Inc. - Key offerings
11.10 Cue Health Inc.
Exhibit 109: Cue Health Inc. - Overview
Exhibit 110: Cue Health Inc. - Product / Service
Exhibit 111: Cue Health Inc. - Key offerings
11.11 Danaher Corp.
Exhibit 112: Danaher Corp. - Overview
Exhibit 113: Danaher Corp. - Business segments
Exhibit 114: Danaher Corp. - Key news
Exhibit 115: Danaher Corp. - Key offerings
Exhibit 116: Danaher Corp. - Segment focus
11.12 DiaSorin SpA
Exhibit 117: DiaSorin SpA - Overview
Exhibit 118: DiaSorin SpA - Business segments
Exhibit 119: DiaSorin SpA - Key news
Exhibit 120: DiaSorin SpA - Key offerings
Exhibit 121: DiaSorin SpA - Segment focus
11.13 F. Hoffmann La Roche Ltd.
Exhibit 122: F. Hoffmann La Roche Ltd. - Overview
Exhibit 123: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 124: F. Hoffmann La Roche Ltd. - Key news
Exhibit 125: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 126: F. Hoffmann La Roche Ltd. - Segment focus
11.14 Hologic Inc.
Exhibit 127: Hologic Inc. - Overview
Exhibit 128: Hologic Inc. - Business segments
Exhibit 129: Hologic Inc. - Key news
Exhibit 130: Hologic Inc. - Key offerings
Exhibit 131: Hologic Inc. - Segment focus
11.15 Laboratory Corp. of America Holdings
Exhibit 132: Laboratory Corp. of America Holdings - Overview
Exhibit 133: Laboratory Corp. of America Holdings - Business segments
Exhibit 134: Laboratory Corp. of America Holdings - Key news
Exhibit 135: Laboratory Corp. of America Holdings - Key offerings
Exhibit 136: Laboratory Corp. of America Holdings - Segment focus
11.16 QIAGEN NV
Exhibit 137: QIAGEN NV - Overview
Exhibit 138: QIAGEN NV - Product / Service
Exhibit 139: QIAGEN NV - Key news
Exhibit 140: QIAGEN NV - Key offerings
11.17 Thermo Fisher Scientific Inc.
Exhibit 141: Thermo Fisher Scientific Inc. - Overview
Exhibit 142: Thermo Fisher Scientific Inc. - Business segments
Exhibit 143: Thermo Fisher Scientific Inc. - Key news
Exhibit 144: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 145: Thermo Fisher Scientific Inc. - Segment focus

12 Appendix

12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Exhibit 146: Inclusions checklist
Exhibit 147: Exclusions checklist
12.3 Currency conversion rates for US$
Exhibit 148: Currency conversion rates for US$
12.4 Research methodology
Exhibit 149: Research methodology
Exhibit 150: Validation techniques employed for market sizing
Exhibit 151: Information sources
12.5 List of abbreviations
Exhibit 152: List of abbreviations

Product Code: IRTNTR43251

Exhibits:

Exhibits1: Executive Summary €" Chart on Market Overview
Exhibits2: Executive Summary €" Data Table on Market Overview
Exhibits3: Executive Summary €" Chart on Country Market Characteristics
Exhibits4: Executive Summary €" Chart on Market By Geographical Landscape
Exhibits5: Executive Summary €" Chart on Market Segmentation by End-user
Exhibits6: Executive Summary €" Chart on Market Segmentation by Type
Exhibits7: Executive Summary €" Chart on Incremental Growth
Exhibits8: Executive Summary €" Data Table on Incremental Growth
Exhibits9: Executive Summary €" Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on North America: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
Exhibits18: Five forces analysis - Comparison between 2022 and 2027
Exhibits19: Chart on Bargaining power of buyers €" Impact of key factors 2022 and 2027
Exhibits20: Bargaining power of suppliers €" Impact of key factors in 2022 and 2027
Exhibits21: Threat of new entrants €" Impact of key factors in 2022 and 2027
Exhibits22: Threat of substitutes €" Impact of key factors in 2022 and 2027
Exhibits23: Threat of rivalry €" Impact of key factors in 2022 and 2027
Exhibits24: Chart on Market condition - Five forces 2022 and 2027
Exhibits25: Chart on End-user - Market share 2022-2027 (%)
Exhibits26: Data Table on End-user - Market share 2022-2027 (%)
Exhibits27: Chart on Comparison by End-user
Exhibits28: Data Table on Comparison by End-user
Exhibits29: Chart on Government - Market size and forecast 2022-2027 ($ billion)
Exhibits30: Data Table on Government - Market size and forecast 2022-2027 ($ billion)
Exhibits31: Chart on Government - Year-over-year growth 2022-2027 (%)
Exhibits32: Data Table on Government - Year-over-year growth 2022-2027 (%)
Exhibits33: Chart on Non-government - Market size and forecast 2022-2027 ($ billion)
Exhibits34: Data Table on Non-government - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Chart on Non-government - Year-over-year growth 2022-2027 (%)
Exhibits36: Data Table on Non-government - Year-over-year growth 2022-2027 (%)
Exhibits37: Market opportunity by End-user ($ billion)
Exhibits38: Data Table on Market opportunity by End-user ($ billion)
Exhibits39: Chart on Type - Market share 2022-2027 (%)
Exhibits40: Data Table on Type - Market share 2022-2027 (%)
Exhibits41: Chart on Comparison by Type
Exhibits42: Data Table on Comparison by Type
Exhibits43: Chart on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Data Table on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
Exhibits45: Chart on Rapid test kit - Year-over-year growth 2022-2027 (%)
Exhibits46: Data Table on Rapid test kit - Year-over-year growth 2022-2027 (%)
Exhibits47: Chart on RT-PCR - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Data Table on RT-PCR - Market size and forecast 2022-2027 ($ billion)
Exhibits49: Chart on RT-PCR - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on RT-PCR - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits52: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits53: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Type ($ billion)
Exhibits56: Data Table on Market opportunity by Type ($ billion)
Exhibits57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits58: Chart on Market share By Geographical Landscape - 2022-2027 (%)
Exhibits59: Data Table on Market share By Geographical Landscape - 2022-2027 (%)
Exhibits60: Chart on Geographic comparison
Exhibits61: Data Table on Geographic comparison
Exhibits62: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits63: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits64: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits65: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits66: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits67: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits68: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits69: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits70: Chart on Mexico - Market size and forecast 2022-2027 ($ billion)
Exhibits71: Data Table on Mexico - Market size and forecast 2022-2027 ($ billion)
Exhibits72: Chart on Mexico - Year-over-year growth 2022-2027 (%)
Exhibits73: Data Table on Mexico - Year-over-year growth 2022-2027 (%)
Exhibits74: Market opportunity By Geographical Landscape ($ billion)
Exhibits75: Data Table on Market opportunity By Geographical Landscape ($ billion)
Exhibits76: Impact of drivers and challenges in 2022 and 2027
Exhibits77: Overview on Criticality of inputs and Factors of differentiation
Exhibits78: Overview on factors of disruption
Exhibits79: Impact of key risks on business
Exhibits80: Vendors covered
Exhibits81: Matrix on vendor position and classification
Exhibits82: Abbott Laboratories - Overview
Exhibits83: Abbott Laboratories - Business segments
Exhibits84: Abbott Laboratories - Key news
Exhibits85: Abbott Laboratories - Key offerings
Exhibits86: Abbott Laboratories - Segment focus
Exhibits87: Advaite Inc. - Overview
Exhibits88: Advaite Inc. - Product / Service
Exhibits89: Advaite Inc. - Key offerings
Exhibits90: Becton Dickinson and Co. - Overview
Exhibits91: Becton Dickinson and Co. - Business segments
Exhibits92: Becton Dickinson and Co. - Key news
Exhibits93: Becton Dickinson and Co. - Key offerings
Exhibits94: Becton Dickinson and Co. - Segment focus
Exhibits95: Biomedomics Inc. - Overview
Exhibits96: Biomedomics Inc. - Product / Service
Exhibits97: Biomedomics Inc. - Key offerings
Exhibits98: bioMerieux SA - Overview
Exhibits99: bioMerieux SA - Product / Service
Exhibits100: bioMerieux SA - Key news
Exhibits101: bioMerieux SA - Key offerings
Exhibits102: Cellex Inc. - Overview
Exhibits103: Cellex Inc. - Product / Service
Exhibits104: Cellex Inc. - Key offerings
Exhibits105: Co Diagnostics Inc. - Overview
Exhibits106: Co Diagnostics Inc. - Product / Service
Exhibits107: Co Diagnostics Inc. - Key news
Exhibits108: Co Diagnostics Inc. - Key offerings
Exhibits109: Cue Health Inc. - Overview
Exhibits110: Cue Health Inc. - Product / Service
Exhibits111: Cue Health Inc. - Key offerings
Exhibits112: Danaher Corp. - Overview
Exhibits113: Danaher Corp. - Business segments
Exhibits114: Danaher Corp. - Key news
Exhibits115: Danaher Corp. - Key offerings
Exhibits116: Danaher Corp. - Segment focus
Exhibits117: DiaSorin SpA - Overview
Exhibits118: DiaSorin SpA - Business segments
Exhibits119: DiaSorin SpA - Key news
Exhibits120: DiaSorin SpA - Key offerings
Exhibits121: DiaSorin SpA - Segment focus
Exhibits122: F. Hoffmann La Roche Ltd. - Overview
Exhibits123: F. Hoffmann La Roche Ltd. - Business segments
Exhibits124: F. Hoffmann La Roche Ltd. - Key news
Exhibits125: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits126: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits127: Hologic Inc. - Overview
Exhibits128: Hologic Inc. - Business segments
Exhibits129: Hologic Inc. - Key news
Exhibits130: Hologic Inc. - Key offerings
Exhibits131: Hologic Inc. - Segment focus
Exhibits132: Laboratory Corp. of America Holdings - Overview
Exhibits133: Laboratory Corp. of America Holdings - Business segments
Exhibits134: Laboratory Corp. of America Holdings - Key news
Exhibits135: Laboratory Corp. of America Holdings - Key offerings
Exhibits136: Laboratory Corp. of America Holdings - Segment focus
Exhibits137: QIAGEN NV - Overview
Exhibits138: QIAGEN NV - Product / Service
Exhibits139: QIAGEN NV - Key news
Exhibits140: QIAGEN NV - Key offerings
Exhibits141: Thermo Fisher Scientific Inc. - Overview
Exhibits142: Thermo Fisher Scientific Inc. - Business segments
Exhibits143: Thermo Fisher Scientific Inc. - Key news
Exhibits144: Thermo Fisher Scientific Inc. - Key offerings
Exhibits145: Thermo Fisher Scientific Inc. - Segment focus
Exhibits146: Inclusions checklist
Exhibits147: Exclusions checklist
Exhibits148: Currency conversion rates for US$
Exhibits149: Research methodology
Exhibits150: Validation techniques employed for market sizing
Exhibits151: Information sources
Exhibits152: List of abbreviations